Holen Sie sich die Stockscreener-App
275.21
2.06%
5.56
Handel nachbörslich:
275.21
Bio Rad Laboratories Inc Aktie (BIO) Neueste Nachrichten
Bio-Rad Laboratories Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
A Look At Bio Rad Laboratories (BIO) Valuation After Recent Share Price Weakness - simplywall.st
(BIO) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Molecular Biology Analyzers Market Set to Boom by 2033: - openPR.com
Microfluidics Research Report 2026-2035: A $20.73 Billion - GlobeNewswire
Microfluidics Research Report 2026-2035: A $20.73 Billion Market by 2030 with Thermo Fisher Scientific, PerkinElmer, Dolomite, Agilent Technologies, Bio-Rad Laboratories, and Fluidigm Leading - Yahoo Finance
Weekly Earnings: What is the long term forecast for Bio Rad Laboratories Inc stockJuly 2025 Reactions & High Win Rate Trade Alerts - baoquankhu1.vn
International Markets and Bio-Rad (BIO): A Deep Dive for Investors - Yahoo Finance
Blood Grouping Reagents Market Top Key Players -Grifols, Roche, - openPR.com
Hemocytometer Market Is Going to Boom Rapidly With Top Key - openPR.com
4 Undervalued Life Sciences Tools & Services Stocks for Thursday, February 19 - AAII
Bio-Rad Updates Investors on Sartorius Strategic Investment Metrics - TipRanks
Bio-Rad Laboratories, Inc. (BIO) achieves modest revenue growth and robust free cash flow growth - MSN
Bio-Rad Laboratories, Inc. (BIO) Achieves Modest Revenue Growth and Robust Free Cash Flow Growth - Finviz
Risk Hedge: Is RBOT still a buy after recent gains2025 Institutional Moves & Stock Timing and Entry Methods - baoquankhu1.vn
Bio-Rad's Q4 Earnings Miss Estimates, Revenues Surpass, Stock Down - Yahoo Finance
Protein Engineering Market to Grow at 15.6% CAGR from 2025 - openPR.com
Protein Engineering Market Is Going to Boom Rapidly With Top Key - openPR.com
Bio-Rad's Timing for Revenue Growth Recovery Remains Uncertain - Morningstar
United States Molecular Quality Controls Market to Reach CAGR - openPR.com
Dematic Automation Solution drives precision and productivity for Bio-Rad Singapore - mhdsupplychain.com.au
MSN Money - MSN
Is It Time To Reassess Bio-Rad Laboratories (BIO) After Multi Year Share Price Weakness - Yahoo Finance
Assessing Bio-Rad Laboratories (BIO) Valuation After Prolonged Share Price Weakness - Yahoo Finance
Bio-Rad Laboratories (BIO) Returns To Profitability With Diagnostics Rebound – Is The Turnaround Durable? - Yahoo Finance
Bio-Rad Laboratories Q4 2025 sales up 9% to USD 693.2M - Medical Buyer
Bio-Rad Laboratories, Inc. (NYSE:BIO) Q4 2025 earnings call transcript - MSN
Bio-Rad Laboratories, Inc. (NYSE:BIO) Q4 2025 Earnings Call Transcript - Insider Monkey
Bio-Rad Laboratories (NYSE:BIO) Lowered to "Hold" Rating by Wall Street Zen - MarketBeat
Beyond the Balance Sheet: What SWOT Reveals About Bio-Rad Labora - GuruFocus
Will Bio Rad Laboratories Inc. benefit from geopolitical trendsWeekly Profit Report & Low Risk Entry Point Tips - mfd.ru
Bio-Rad Q4 2025 slides reveal modest growth amid segment divergence and strategic shifts - Investing.com Nigeria
Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap DownHere's What Happened - MarketBeat
Bio-Rad Laboratories Inc (BIO) Shares Down 11.17% on Feb 13 - GuruFocus
Oversold Conditions For Bio-Rad Laboratories (BIO) - Nasdaq
UBS Adjusts Price Target on Bio-Rad Laboratories to $335 From $350, Maintains Buy Rating - marketscreener.com
Bio-Rad Laboratories (BIO) Shares Cross Below 200 DMA - Nasdaq
Bio-Rad Laboratories (NYSE:BIO) Shares Gap Down After Earnings Miss - MarketBeat
Bio-Rad Laboratories, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Pinterest Posts Downbeat Results, Joins DraftKings, Toast, Expedia And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
S&P 500 Futures Drop In Premarket Trading; Pinterest, Bio-Rad Labs A Lag - 富途牛牛
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
BIO-RAD LABORATORIES, INC. SEC 10-K Report - TradingView
Bio-Rad (BIO) Reports Q4 Revenue Growth and Strategic Initiatives - GuruFocus
Bio-Rad Laboratories, Inc. $BIO Holdings Lifted by Envestnet Asset Management Inc. - MarketBeat
Bio-Rad outlines 2026 margin expansion and 0.5%-1.5% revenue growth guidance amid operational improvements - MSN
Bio-Rad Laboratories Q4 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Bio-Rad Labs Q4 2025 misses EPS expectations - Investing.com Australia
Bio-Rad Laboratories Q4 Earnings Call Highlights - MarketBeat
Earnings call transcript: Bio-Rad Labs Q4 2025 misses EPS expectations By Investing.com - Investing.com South Africa
Bio-Rad Laboratories (NYSE:BIO.B) Posts Quarterly Earnings Results - MarketBeat
Bio-Rad (BIO) Q4 2025 Earnings Call Transcript - AOL.com
Bio-Rad: Q4 Earnings Snapshot - KVUE
BIO: 2025 results met guidance with diagnostics growth, ddPCR momentum, and cautious 2026 outlook - TradingView
BIO: 2025 saw resilient revenue and cash flow, with diagnostics growth and ddPCR momentum offsetting margin pressures - TradingView
1.14%
0.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):